HCPCS Codes 2018 for Q0180 : Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen

HCPCS 2018

	Q0180	Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
	Added on: Wednesday, April 04, 1998
	Status changed on: Wednesday, April 04, 1998
	BETOS Classification : Chemotherapy
	Medicare coverage status:Special coverage instructions apply